Rodriguez PJ, Goodwin Cartwright BM, Gratzl S, Brar R, Baker C, Gluckman TJ, et al
The rapid divergence observed in mortality, MACE, and MAKE almost immediately after the start of follow-up prompted us to explore alternative mechanisms beyond general metabolic improvements
However, these side effects are usually manageable and subside over time
In the studies Ive read where people stopped taking a GLP-1 , most of them regained much of the weight within a year, and their blood sugar benefits faded too
Glp-1r / mice had no insulinotropic response to EX-4 compared to the robust insulin secretion peaks seen in the hGLP-1R and mGlp-1r animals during the IPGTT ( Figure 3B )